Viome Life Sciences introduced it closed a $86.5 million oversubscribed Collection C funding spherical, bringing its whole increase to $175 million.
Daring Capital and Khosla Ventures participated within the spherical alongside current and new buyers.
The corporate additionally introduced the launch of its Intestine Intelligence Take a look at in 200 CVS places.
WHAT THEY DO
The corporate gives a complete physique intelligence take a look at for customers to acquire meals suggestions and create custom-formulated dietary supplements and probiotics, which the corporate additionally develops and distributes.
Viome additionally gives an oral well being intelligence take a look at with its VRx My·Biotics Oral Lozenges focused at evaluating and bettering one’s oral micro organism.
The Washington-based firm’s Intestine Intelligence Take a look at, out there by way of CVS on-line and in-store, evaluates one’s digestive effectivity, intestine lining well being, gasoline manufacturing, protein fermentation, inflammatory exercise, metabolic health, intestine energetic microbial variety, and microbiome-induced stress. The goal is to assist one perceive their intestine well being and acquire suggestions for probiotic strains and prebiotic fibers.
The corporate will use the funds from the Collection C spherical to additional analysis and develop its suite of well being checks and proceed its growth into retailers.
“Amidst the surge in persistent situations and the inflow of conflicting dietary recommendation flooding social media, it turned evident {that a} seismic shift was crucial. At Viome, we’re not simply speaking about wellness; we’re creating a complete new understanding of what it means to be wholesome by addressing the foundation explanation for points and never simply the signs. By combining our deep understanding of particular person uniqueness and the microbiome with cutting-edge RNA sequencing and AI know-how, we’re capable of translate knowledge into actionable insights that may profoundly influence our healthspan and lifespan. I really feel grateful to have the assist of buyers and companions who actually perceive and admire our groundbreaking work. The most recent funding and our growth into CVS characterize extra than simply enterprise milestones; they are a testomony to our dedication and a chance for us to speed up our studying as we get nearer to reaching our mission of serving to billions of individuals stay higher lives,” Naveen Jain, founder and CEO of Viome, informed MobiHealthNews in an e mail.
MARKET SNAPSHOT
In 2021, Viome introduced it raised $54 million in a pre-Series C convertible funding round. The corporate scored $56 million in Collection B funding in 2019 and $15 million in August 2017.
Viome obtained FDA breakthrough device designation for its mRNA evaluation know-how and AI platform in 2021 that detects early indicators of oral and throat most cancers by way of person saliva samples.
Different firms providing residence testing kits embody Reperio Health, the maker of an app-connected residence wellness evaluation equipment marketed to employers; residence diagnostics firm Cue Health; and Everly Health, the mother or father firm of at-home diagnostics startup EverlyWell and being pregnant and fertility-focused Natalist.
